Oculis Holding accelerates enrollment in both DIAMOND phase 3 trials of OCS-01 in diabetic macular edema: Zug, Switzerland Tuesday, October 22, 2024, 12:00 Hrs [IST] Oculis Holdin ...
GSK & Cambridge University announce new five-year collaboration in kidney and respiratory disease: London, UK Tuesday, October 22, 2024, 10:00 Hrs [IST] GSK plc announced it is in ...
Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...
HBA convenes global healthcare pharma, companies to advance women leadership in Indian healthcare: Our Bureau, Mumbai Monday, ...
Gujarat has two new and one upgraded drug testing lab in Surat, Rajkot and Vadodara: Dr Koshia: Shardul Nautiyal, Mumbai Tuesday, October 22, 2024, 08:00 Hrs [IST] Gujarat’s bur ...
Indian healthcare industry sees advanced on-site 3D printing lab to simplify preoperative planning: Nandita Vijayasimha, Bengaluru Tuesday, October 22, 2024, 08:00 Hrs [IST] The I ...
Digital transformation of TN DCA increased efficiency of licensing process in TN: M Sridhar: Peethaambaran Kunnathoor, Chennai Tuesday, October 22, 2024, 08:00 Hrs [IST] The digit ...
The pharmaceutical exporters in the country are keenly awaiting a government response to their call for an exemption from the stringent payment conditions under Section 43B (h) of the Income Tax (IT) ...
DoP rejects review application of Pfizer Ltd against ceiling price fixation of Wysolone DT: Gireesh Babu, New Delhi Tuesday, October 22, 2024, 08:00 Hrs [IST] The Department of Ph ...
Evergreen Theragnostics opens trial of 68Ga-EVG321 for patients with small cell lung cancer in European Union: Springfield, New Jersey Monday, October 21, 2024, 18:00 Hrs [IST] Ev ...
Akums inks licensing pact with Triple Hair Group, Canada for patented topical solution targeting alopecia: Our Bureau, Bengaluru Monday, October 21, 2024, 16:30 Hrs [IST] Akums Dr ...
Xenetic Biosciences inks materials transfer agreement with Tokyo Medical University for advancement of DNase-based oncology platform: Framingham, Massachusetts Monday, October 21, ...